Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.
Nicholas A ZorkoAllison MakovecAndrew ElliottSamuel KellenJohn R LozadaAli T ArafaMartin FelicesMadison ShackelfordPedro BarataYousef ZakhariaVivek NarayanMark N SteinKevin K ZarrabiAkash PatniakMehmet A BilenMilan RadovichGeorge SledgeWafik S El-DeiryElisabeth I HeathDave S B HoonChadi NabhanJeffrey S MillerJustin H HwangEmmanuel S AntonarakisPublished in: Prostate cancer and prostatic diseases (2024)
Using the largest available dataset to date, we demonstrated that NK cells infiltrate a broad range of tumors, including both primary and metastatic PCa. NK cell infiltration is associated with improved PCa patient outcomes. This study demonstrates that NK cells are capable of trafficking to both primary and metastatic PCa and are a viable option for immunotherapy approaches moving forward. Future development of strategies to enhance tumor-infiltrating NK cell-mediated cytolytic activity and activation while limiting inhibitory pathways will be key.